Heparanase, MMP9, vimentin, and VEGF-B protein levels, were studied in both tumor and non-tumor adjacent tissues of all stages from CRC patients (see Figure 1 and Figure 4). The gene discussed is VIM; the disease is colorectal carcinoma.